Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.36
-0.03 (-0.47%)
At close: May 8, 2026, 4:00 PM EDT
6.31
-0.05 (-0.79%)
After-hours: May 8, 2026, 6:19 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $418.84 million as of May 8, 2026. Its market cap has decreased by -42.97% in one year.
Market Cap
418.84M
Enterprise Value
533.95M
1-Year Change
-42.97%
Ranking
Category
Stock Price
$6.36
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $418.84M, an increase of 54.38%. That is a compound annual growth rate of 5.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 418.80M | -2.85% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 808.25M |
| BioAge Labs | 798.72M |
| Ironwood Pharmaceuticals | 694.67M |
| Tilray Brands | 663.21M |
| Aquestive Therapeutics | 536.91M |
| Kamada | 496.27M |
| Emergent BioSolutions | 490.16M |
| Canopy Growth | 428.41M |